MapLight Therapeutics IPO

Maplight Therapeutics is a drug discovery platform utilizing transcriptomics and optogenetics to find treatments for brain disorders and symptoms.

Register for Details

For more details on financing and valuation for MapLight Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is MapLight Therapeutics's ticker symbol?

MapLight Therapeutics does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

What is MapLight Therapeutics's stock price?

The stock price for MapLight Therapeutics will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

MapLight Therapeutics Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
10/25/2022 Series B-1 $246.63MM $XXX.XX $XXX.XX
10/23/2021 Series B $118.86MM $XXX.XX $XXX.XX
8/23/2019 Series A-1 $61.01MM $XXX.XX $XXX.XX
2/22/2019 Series A $20MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about MapLight Therapeutics

What is MapLight Therapeutics funding to date?

MapLight Therapeutics has raised $63MM with the following series:
$20MM for Series A, $61.01MM for Series A-1, $118.86MM for Series B, $246.63MM for Series B-1

When was MapLight Therapeutics founded?

MapLight Therapeutics was founded in 2018.

Can you invest in MapLight Therapeutics?

MapLight Therapeutics is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell MapLight Therapeutics share pre-IPO?

If you own MapLight Therapeutics pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Is MapLight Therapeutics a publicly traded company?

MapLight Therapeutics is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Other companies like MapLight Therapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$298.33MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$327.39MM
Sector
 
 
Sector
Last Round Est. Valuation
$500MM